Celularity Inc
(CELU)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,501 | -22,013 | -196,295 | -205,842 | -111,966 |
| Depreciation Amortization | 4,152 | 2,156 | 121,671 | 119,375 | 34,318 |
| Accounts receivable | -3,732 | -3,924 | -6,827 | -118 | 1,266 |
| Other Working Capital | 1,919 | -2,111 | 3,252 | 34,141 | 32,324 |
| Other Operating Activity | 18,311 | 21,489 | 39,514 | 18,100 | 18,036 |
| Operating Cash Flow | $-7,851 | $-4,403 | $-38,685 | $-34,344 | $-26,022 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -70 | -39 | -1,048 | -468 | -240 |
| Other Investing Activity | 2,175 | 0 | -3,000 | -3,000 | -3,000 |
| Investing Cash Flow | $2,105 | $-39 | $-4,048 | $-3,468 | $-3,240 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 17,993 | 17,993 | 20,369 | 20,369 | 17,369 |
| Debt Issued | 6,000 | 6,000 | 12,750 | 12,750 | 12,750 |
| Common Stock Issued | N/A | N/A | 440 | 440 | 440 |
| Other Financing Activity | -17,856 | -17,766 | -9,465 | -9,451 | -12,190 |
| Financing Cash Flow | $6,137 | $6,227 | $24,094 | $24,108 | $18,369 |
| Beginning Cash Position | 10,163 | 10,163 | 28,802 | 28,802 | 28,802 |
| End Cash Position | 10,554 | 11,948 | 10,163 | 15,098 | 17,909 |
| Net Cash Flow | $391 | $1,785 | $-18,639 | $-13,704 | $-10,893 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,851 | -4,403 | -38,685 | -34,344 | -26,022 |
| Capital Expenditure | -70 | -39 | -1,048 | -468 | -240 |
| Free Cash Flow | -7,921 | -4,442 | -39,733 | -34,812 | -26,262 |